本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2009/5/111 分钟阅读
New Animal Drugs; Trilostane
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the original approval of a new animal drug application (NADA) filed by Dechra, Ltd. The NADA provides for the veterinary prescription use of trilostane capsules in dogs for treatment of pituitary-dependent hyperadrenocorticism and for treatment of hyperadrenocorticism due to adrenocortical tumor.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →